Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Conference Call October 31, 2023 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Charles Kummeth - Chief Executive Officer James Hippel - Chief Financial Officer Kim Kelderman - Chief Operating Officer. Conference Call Participants Puneet Souda - SVB Securities Patrick Donnelly - Citi Catherine Schulte - Baird Matthew Larew - William Blair Alex Nowak - Craig-Hallum Paul Knight - KeyBanc Justin Bowers - Deutsche Bank Operat ...

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023, or Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K Securities registered pursuant to Section 12(b) of the Act: ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in it ...

Bio-Techne Corporation (NASDAQ:TECH) Q4 2023 Earnings Conference Call August 8, 2023 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Chuck Kummeth – Chief Executive Officer Jim Hippel – Chief Financial Officer Will Geist – President-Protein Sciences Segment Conference Call Participants Puneet Souda – Leerink Partners Patrick Donnelly – Citi Jacob Johnson – Stephens Dan Arias – Stifel Dan Leonard – Credit Suisse Catherine Schulte – Baird Operator Good morning, and welcome to t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jur ...

Bio-Techne Corporation (NASDAQ:TECH) Q3 2023 Earnings Conference Call May 3, 2023 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Chuck Kummeth – Chief Executive Officer Jim Hippel – Chief Financial Officer Conference Call Participants Puneet Souda – SVB Securities Jacob Johnson – Stephens Dan Arias – Stifel Dan Leonard – Credit Suisse Patrick Donnelly – Citi Catherine Schulte – Baird Justin Bowers – Deutsche Bank Alex Nowak – Craig-Hallum Operator Good day, and welcome to th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other ...

Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Conference Call February 2, 2023 9:00 AM ET Company Participants David Clair - Vice President of Investor Relations Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Securities Jacob Johnson - Stephens Dan Arias - Stifel Dan Leonard - Credit Suisse Catherine Schulte - Baird Patrick Donnelly - Citi Justin Bowers - Deutsche Bank Operator Good morning, and welcome to the Bio-Techne E ...

Table of Contents ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022, or Minnesota 41-1427402 (State or other ...

Bio-Techne Corporation (NASDAQ:TECH) Q1 2023 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Chuck Kummeth - President, Chief Executive Officer Jim Hippel - Executive Vice President, Chief Financial Officer David Clair - Vice President, Investor Relations Conference Call Participants Puneet Souda - SVB Securities Dan Arias - Stifel Dan Leonard - Credit Suisse Anna - Stephens Alex Nowak - Craig Hallum Catherine Schulte - Baird Patrick Donnelly - Citi Operator Good morning and wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jurisdiction ...